Lexicon Pharmaceuticals (LXRX) Non-Current Deferred Tax Liability (2010 - 2019)

Lexicon Pharmaceuticals (LXRX) has reported Non-Current Deferred Tax Liability for 10 consecutive years, with $6.0 million the latest figure, recorded in Q2 2019.

• In Q2 2019, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $6.0 million; the TTM figure through Jun 2019 stood at $6.0 million (changed 0.0% YoY), while the FY2018 annual figure was $6.0 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability was little changed at $6.0 million in Q2 2019 per LXRX's latest filing, from $6.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $18.7 million in Q1 2015 and bottomed at $6.0 million in Q4 2017.
• Historically, Non-Current Deferred Tax Liability has averaged $12.3 million across 5 years, with a median of $10.0 million in 2017.
• Annual changes were most pronounced in 2015 — Non-Current Deferred Tax Liability changed 0.0% — and 2017, when it sank 67.8%.
• Lexicon Pharmaceuticals' Non-Current Deferred Tax Liability stood at $18.7 million in 2015, then changed by 0.0% to $18.7 million in 2016, then tumbled by 67.8% to $6.0 million in 2017, then changed by 0.0% to $6.0 million in 2018, then changed by 0.0% to $6.0 million in 2019.
• Business Quant data shows LXRX's Non-Current Deferred Tax Liability at $6.0 million in Q2 2019, $6.0 million in Q1 2019, and $6.0 million in Q4 2018.